TrueBlue Inc (TBI)
Official siteINDUSTRIALS • STAFFING & EMPLOYMENT SERVICES • NYSE
Market Cap: $370.69M
Last updated: Nov 17, 2026 at 4:10 PM ET
TrueBlue Inc (TBI) Statistics
TrueBlue (TBI) has a market cap of $370.69M and an enterprise value of $453.22M. It earned -$45.45M on revenue of $1.78B over the last 12 months.
Total Valuation
Enterprise value is 22.26% above the market cap, as debt exceeds cash.
| Market Cap | $370.69M |
|---|---|
| Enterprise Value | $453.22M |
| Latest price (Nov 17, 2026) | $11.81 |
Key Dates
The next earnings report is expected on Feb 16, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 16, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.2x and 1.3x. Its year-end P/S ranged from 0.2x to 0.5x from 2016 to 2024.
| P/S Ratio | 0.2x |
|---|---|
| Forward P/S | 0.2x |
| P/B Ratio | 1.3x |
| P/TBV Ratio | 1.7x |
Price Statistics
The stock is up 140.53% over 52 weeks and trades 21.25% above its 50-day average.
| Beta (1Y) | 0.02 |
|---|---|
| 52-Week Change | +140.53% |
| 1-Month Change | +44.91% |
| 3-Month Change | +8.85% |
| 6-Month Change | +119.93% |
| 5-Year Change | -64.92% |
| 10-Year Change | -44.17% |
| Total Return (1Y) | +140.53% |
| Total Return (3Y CAGR) | -4.87% |
| Total Return (5Y CAGR) | -14.64% |
| Return vs SPY (1Y) | +142.42% |
| Max Drawdown (1Y) | -40.25% |
| Max Drawdown (3Y) | -79.16% |
| Sharpe Ratio (1Y) | 1.34 |
| Correlation with SPY (1Y) | 0.00 |
| 50-Day Average | $9.74 |
| 200-Day Average | $7.17 |
| 52-Week Range | $3.18 to $13.59 |
| RSI (14 Days) | 63.5 |
| Average Volume (20 Days) | 316.12K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.33x current liabilities, and total debt is 0.38x shareholder equity.
| Current Ratio | 2.33x |
|---|---|
| Quick Ratio | 2.33x |
| Debt / Equity | 0.38x |
Returns and Efficiency
Return on invested capital is -11.07% over the last 12 months, against a 5-year average of -13.70%.
| Return on Equity (ROE) | -17.05% |
|---|---|
| Return on Assets (ROA) | -6.77% |
| Return on Invested Capital (ROIC) | -11.07% |
| Return on Capital Employed (ROCE) | -8.00% |
| ROE (5Y Average) | -7.08% |
| ROA (5Y Average) | -3.13% |
| ROIC (5Y Average) | -13.70% |
| Asset Turnover | 2.62x |
| Receivables Turnover | 5.99x |
Scores
TBI has an Altman Z-Score of 3.97, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.97 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.78B over the last 12 months is up 12.42% from the 12 months before.
| Revenue | $1.78B |
|---|---|
| Revenue Growth (YoY) | +12.42% |
| Gross Profit | $367.64M |
| Operating Income | -$36.44M |
| Pretax Income | -$41.88M |
| Net Income | -$45.45M |
| EBITDA | -$13.18M |
| EBIT | -$40.85M |
| Reported EPS (TTM) | -$0.27 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 39.72% of the $671.17M in total assets.
| Cash and Equivalents | $19.77M |
|---|---|
| Total Debt | $102.30M |
| Net Debt | $82.53M |
| Net Debt Per Share | $2.71 |
| Working Capital | $213.90M |
| Shareholder Equity | $266.60M |
| Book Value Per Share | $8.76 |
| Tangible Book Value | $211.43M |
| Tangible Book Per Share | $6.95 |
| Total Assets | $671.17M |
| Total Liabilities | $404.57M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $11.53M of capital spending, operating cash flow left -$72.31M of free cash flow.
| Operating Cash Flow | -$60.77M |
|---|---|
| Capital Expenditures | $11.53M |
| Free Cash Flow | -$72.31M |
| FCF Per Share | -$2.38 |
| Depreciation and Amortization | $27.67M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -2.05%, against a 5-year average of -0.74%.
| Gross Margin | 20.65% |
|---|---|
| Operating Margin | -2.05% |
| Pretax Margin | -2.35% |
| Net Margin | -2.55% |
| EBITDA Margin | -0.74% |
| EBIT Margin | -2.29% |
| FCF Margin | -4.06% |
| Gross Margin (5Y Average) | 25.55% |
| Operating Margin (5Y Average) | -0.74% |
| Net Margin (5Y Average) | -1.23% |
Growth
Revenue fell 10.50% a year over 3 years.
| Revenue Growth (3Y CAGR) | -10.50% |
|---|---|
| Revenue Growth (5Y CAGR) | -2.63% |
| Book Value Per Share Growth (2Y CAGR) | -21.11% |
| Tangible Book Per Share Growth (2Y CAGR) | -21.81% |
Dividends and Yields
TBI does not pay a dividend. Its free cash flow yield is -20.11%.
| FCF Yield | -20.11% |
|---|---|
| Buyback Yield | -0.08% |
| Shareholder Yield | -0.08% |
Stock Splits
The last split was a 3-for-2 forward split on Jul 13, 1999.
| Last Split Date | Jul 13, 1999 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 3:2 |
Peer Position
Against 11 similar companies, TBI has the 9th highest P/S.
P/S RatioPeer median 0.6x
ROICPeer median 3.82%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +3.42%
| P/S Ratio | 0.2x vs 0.6x median |
|---|---|
| ROIC | -11.07% vs 3.82% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +12.42% vs +3.42% median |
Analyst Forecast
Consensus estimates put revenue growth at 8.86% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +8.86% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About TBI
What is TBI's market cap?
TrueBlue has a market cap of $370.69M. Its enterprise value, which adds debt and subtracts cash, is $453.22M.
How many shares of TBI are outstanding?
TrueBlue has 30.44M shares outstanding. The count is up 1.82% from a year earlier.
Does TBI pay a dividend?
No. TrueBlue does not pay a dividend.
How much debt does TBI have?
TrueBlue has $102.30M of total debt and $19.77M of cash and equivalents, a net debt position of $82.53M.
TBI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors